Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.13 USD | -0.13% | -.--% | +12.83% |
May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Director/Board Member | 46 | 19-09-18 | |
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Director/Board Member | 46 | 19-09-18 | |
Ana Radeljevic
BRD | Director/Board Member | 44 | 22-06-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,788,369 | 14,612,210 ( 98.81 %) | 0 | 98.81 % |
Company contact information
Merrimack Pharmaceuticals, Inc.
One Broadway 14th Floor
02142, Cambridge
+
http://www.merrimackpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+12.83% | 224M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- MACK Stock
- Company Merrimack Pharmaceuticals, Inc.